Blood test could warn cancer patients of dangerous treatment side effects
NCT ID NCT05973344
Summary
This study aims to find markers in the blood that can predict which cancer patients will develop serious side effects from a common type of immunotherapy. Researchers will collect blood samples from 200 patients at a single hospital in France during their regular cancer check-ups. By analyzing these samples, they hope to learn how to better manage treatment and improve safety for patients receiving these powerful drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brest University Hospital
RECRUITINGBrest, 29200, France
Contact
Conditions
Explore the condition pages connected to this study.